EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Open Access

An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm

Gamze Kilic-Berkmen iD, Hodam Kim, Dongdong Chen, Cameron I Yeo, Ashok R Dinasarapu, Laura M Scorr iD, Woon-Hong Yeo, David A Peterson iD, Hilde Williams, April Ruby, Roger Mills, H A Jinnah

Movement Disorders · 2024-04 · 39 (4) · 738-745

DOI: 10.1002/mds.29734 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Movement Disorders, online erschienen am 03.02.2024. Verfasst von Gamze Kilic-Berkmen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Blepharospasm. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCATS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Blepharospasm is treated with botulinum toxin, but obtaining satisfactory results is sometimes challenging.

Objective

The aim is to conduct an exploratory trial of oral dipraglurant for blepharospasm.

Methods

This study was an exploratory, phase 2a, randomized, double‐blind, placebo‐controlled trial of 15 participants who were assigned to receive a placebo or dipraglurant (50 or 100 mg) and assessed over 2 days, 1 and 2 hours following dosing. Outcome measures included multiple scales rated by clinicians or participants, digital video, and a wearable sensor.

Results

Dipraglurant was well tolerated, with no obvious impact on any of the measurement outcomes. Power analyses suggested fewer subjects would be required for studies using a within‐subject versus independent group design, especially for certain measures. Some outcome measures appeared more suitable than others.

Conclusion

Although dipraglurant appeared well tolerated, it did not produce a trend for clinical benefit. The results provide valuable information for planning further trials in blepharospasm. © 2024 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BlepharospasmHumansDouble-Blind MethodMaleFemaleMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

blepharospasmdipraglurantdystoniaglutamatetrial

Autor:innen und Institutionen

  • Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of IEN Center for Human-Centric Interfaces and Engineering, The Institute for Electronics and Nanotechnology, Georgia Institute of Technology, Atlanta, Georgia, USA.
  • Department of George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Departments of Parker H. Petit Institute for Bioengineering and Biosciences, Institute for Materials, Neural Engineering Center, Institute for Robotics and Intelligent Machines, Georgia Institute of Technology, Atlanta,…
  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech and Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Gamze Kilic-Berkmen, Laura M Scorr, David A Peterson

Förderung

  • NINDS NIH HHS
  • NCATS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Kilic-Berkmen, G., Kim, H., Chen, D., Yeo, C. I., Dinasarapu, A. R., Scorr, L. M., Yeo, W. H., Peterson, D. A., Williams, H., Ruby, A., Mills, R., & Jinnah, H. A. (2024). An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm. Movement Disorders, 39(4), 738-745. https://doi.org/10.1002/mds.29734

Vancouver

Kilic-Berkmen G, Kim H, Chen D, Yeo CI, Dinasarapu AR, Scorr LM, et al. An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm. Movement Disorders. 2024;39(4):738-745. doi:10.1002/mds.29734

BibTeX
@article{KilicBerkmen2024,
  author = {Kilic-Berkmen, Gamze and Kim, Hodam and Chen, Dongdong and Yeo, Cameron I and Dinasarapu, Ashok R and Scorr, Laura M and Yeo, Woon-Hong and Peterson, David A and Williams, Hilde and Ruby, April and Mills, Roger and Jinnah, H A},
  title = {An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {4},
  pages = {738--745},
  doi = {10.1002/mds.29734}
}
Kostenlos starten →